Breakingviews: Trump’s grain of truth makes biotechs vulnerable

Donald Trump's stream of consciousness involves at least moments of truth. The U.S. president-elect said he dislikes what has happened to drug prices, and biotech stocks slumped by more than 2 percent on Wednesday. Hillary Clinton's campaign statements similarly dented shares in the sector. They're vulnerable because the jabs are justified.